Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 May 13;8(5):e62737.
doi: 10.1371/journal.pone.0062737. Print 2013.

Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis

Shi-ming Cheng  1 , Yi-fan Feng, Ling Xu, Yan Li, Jin-hai Huang
Affiliations
Meta-Analysis

Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis

Shi-ming Cheng et al. PLoS One. .

Abstract

Background: A number of published comparative studies have been conducted to evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in endoscopic dacryocystorhinostomy (EN-DCR). However, results have not always been consistent. Therefore, we carried out a meta-analysis to compare the clinical results of EN-DCR with and without MMC.

Methods and findings: A comprehensive literature search of Cochrane Library, PubMed and EMBASE to identify relevant trials comparing EN-DCR with and without MMC. Eleven studies including 574 eyes were included in this meta-analysis. The success was defined as patency of the nasolacrimal canal and symptomatic improvement. There was significantly higher success rate in the MMC group in comparison with control group [RR = 1.12, 95% CI (1.04, 1.20), P = 0.004]. A sensitivity analysis after the non-randomized controlled trials were excluded from the meta-analysis demonstrated no differences compared with the overall results. Subgroup analyses showed that MMC group had a significantly higher success rate than control group in primary and revision EN-DCR, and EN-DCR without silicone intubation, but no difference in the subgroup of with silicone intubation. The size of the osteotomy site was bigger in the MMC group compared to the control group at 3 months [WMD = 7.65, 95% CI (0.33, 14.98), P = 0.041] and 6 months [WMD = 9.28, 95% CI (2.45, 16.11), P = 0.008] after surgery. However, there was statistically significant difference in the osteotomy surface area between the two groups at 12 months after surgery [WMD = 11.63, 95% CI (-1.04, 24.29), P = 0.072].

Conclusion: Intraoperative MMC application seems to be a safe adjuvant that could reduce the closure rate of the osteotomy and enhance the success rate after both primary and revision EN-DCR.

Trial registration: ClinicalTrials.gov NCT01772277.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Search and study selection process.
Figure 2
Figure 2. The success rate of endoscopic dacryocystorhinostomy with and without Mitomycin C.
Figure 3
Figure 3. Sensitivity analysis of the success rate of endoscopic dacryocystorhinostomy with and without Mitomycin C.
Figure 4
Figure 4. Subgroup analysis of the success rate of endoscopic dacryocystorhinostomy with and without Mitomycin C.
Figure 5
Figure 5. Subgroup analysis of the success rate of endoscopic dacryocystorhinostomy with and without Mitomycin C.
Figure 6
Figure 6. The mean ostium size of endoscopic dacryocystorhinostomy with and without Mitomycin C after surgery.
Figure 7
Figure 7. Begg’s funnel plot for the success rate of endoscopic dacryocystorhinostomy.
See this image and copyright information in PMC

References

    1. Caldwell GW (1893) Two new operations for obstruction of the nasal duct with preservation of the canaliculi. Am J Ophthalmol 10: 189–191.
    1. McDonogh M, Meiring JH (1989) Endoscopic transnasal dacryocystorhinostomy. J Laryngol Otol 103: 585–587. - PubMed
    1. Korkut AY, Teker AM, Yazici MZ, Kahya V, Gedikli O, et al. (2010) Surgical outcomes of primary and revision endoscopic dacryocystorhinostomy. J Craniofac Surg 21: 1706–1708. - PubMed
    1. Leong SC, Macewen CJ, White PS (2010) A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allergy 24: 81–90. - PubMed
    1. Wakaki S, Marumo H, Tomioka K (1958) Isolation of new fractions of antitumor mitomycins. Antibiot Chemother 8: 228–240. - PubMed

Associated data